Vaccines, encephalopathies, and mutations

Comment

Anne T Berg. Epilepsy Curr. 2007 Mar-Apr.

. 2007 Mar-Apr;7(2):40-2.

doi: 10.1111/j.1535-7511.2007.00163.x.

No abstract available

Comment on

De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study.
Berkovic SF, Harkin L, McMahon JM, Pelekanos JT, Zuberi SM, Wirrell EC, Gill DS, Iona X, Mulley JC, Scheffer IE. Berkovic SF, et al. Lancet Neurol. 2006 Jun;5(6):488-92. doi: 10.1016/S1474-4422(06)70446-X. Lancet Neurol. 2006. PMID: 16713920

1. Dravet Ch, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy (Dravet Syndrome) In: Roger J, Bureau M, Dravet Ch, Genton P, Tassinari CA, Wolf P, editors. Epileptic Syndromes in Infancy, Childhood and Adolescence. Eastleigh, UK: John Libbey & Co; 2002. pp. 81–103.
1. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus a genetic disorder with heterogeneous clinical phenotypes. Brain. 1997;120:479–490. - PubMed
1. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68:1327–1332. - PMC - PubMed
1. Kanai K, Hirose S, Oguni H, Fukuma G, Shirasaka Y, Miyajima T, Wada K, Iwasa H, Yasumoto S, Matsuo M, Ito M, Mitsudome A, Kaneko S. Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity. Neurology. 2004;63:329–334. - PubMed
1. Bonanni P, Malcarne M, Moro F, Veggiotti P, Buti D, Ferrari AR, Parrini E, Mei D, Volzone A, Zara F, Heron SE, Bordo L, Marini C, Guerrini R. Generalized epilepsy with febrile seizures plus (GEFS): clinical spectrum in seven Italian families unrelated to SCN1A, and GABRG2 gene mutations. Epilepsia. 2004;45:149–158. - PubMed